Jehanzeb Riaz, MD

Oncologist

4.5 out of 5

(90 Ratings) , 17 Comments

Position: Oncologist
Primary Specialty: Hematology & Oncology
Languages Spoken: Hindi, Urdu, English
Gender: Male

About Jehanzeb Riaz

Jehanzeb Riaz is a medical oncologist at OU Health in Tulsa. He completed his residency at Mount Sinai School of Medicine, Jersey City Medical Center in Jersey City, NJ, and he completed a fellowship at Texas Tech University Health Sciences Center in Lubbock, TX.

He treats patients with all common cancers, including breast, lung, colon, prostate, kidney, bladder, head and neck, brain tumors, melanoma and other skin cancers, thyroid, sarcomas, lymphomas and multiple myeloma.

Riaz is passionate about helping people understand their disease, challenges and treatment options to maximize their chance to beat the cancer, prolong survival and improve quality of life.

Health Education

Medical School
Doctor of Medicine University of Health Sciences, Allama Iqbal Medical College
Lahore

Residency
Internal Medicine Mount Sinai School of Medicine
Jersey City, NJ

Fellowship
Medical Oncology Texas Tech University Health Sciences Center
Lubbuck, TX

Reviews

05/03/2026

Good
04/05/2026

He is always informative and thorough.
04/05/2026

That already polite, glad to see us both, see if we need a drink of water.
04/05/2026

Consultation started OK but went downhill quickly. He described what I had and the standard treatment journey for this problem. I had been previously been consulting with an oncologist friend from another country and had started a protocol recommended by him. I showed the Dr. The protocol and asked if he had any problems with me continuing that protocol while doing radiation and chemotherapy. My friend has been doing this with great success side by side but warned me it may not be accepted in the US. At that time I was berated and and scolded for even trying such a thing and said that what I was doing had been "debunked". That pretty much ended any further discussion about options, risks, benefits, or my involvement in my care. After leaving I researched and found on the NIH website that they were doing clinical trials with this protocol on certain types of cancers. I also found other current studies from treatment centers including this option. Needless to say I'm not impressed and even concerned about my treatment.